Stonerise Capital Management lowered its stake in Nashville, Tenn.-based AmSurg by 50 percent in the third quarter, the Daily Quint reports.
Here are five points:
1. During Q3, the firm sold 250,000 AmSurg shares.
2. AmSurg comprises nearly 4.1 percent of Stonerise Capital Management's portfolio.
3. As of it most recent filing with the U.S. Securities and Exchange Commission, Stonerise Capital Management owned 0.13 percent of AmSurg.
4. On Feb. 8, 2017, AmSurg shares increased 0.7 percent, reaching $69.02.
5. AmSurg's market cap totals $3.71 billion.